D&D Pharmatech Inc.
Develops oral & injectable peptide therapies for metabolic & chronic diseases like obesity.
347850 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 수정구 금토로80번길 27 (금토동, 텔레칩스) 4층, 성남시
- Website:
- http://www.ddpharmatech.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
D&D Pharmatech Inc. is a clinical-stage global biotechnology company focused on developing novel peptide-based therapies for metabolic and chronic diseases with high unmet medical needs. The company's core research centers on its portfolio of GLP-1 (Glucagon-like peptide-1) class drugs, targeting conditions such as obesity and MASH (Metabolic dysfunction-associated steatohepatitis). A key competency is its advanced oral peptide technology, which enables the creation of oral treatments in addition to injectable therapies. D&D Pharmatech operates a dual-center model, with a research team in Korea dedicated to peptide discovery and a clinical development team in the United States managing global trials and regulatory processes.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for D&D Pharmatech Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all D&D Pharmatech Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for D&D Pharmatech Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
